PLoS Biology (May 2022)

No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination

  • Alice Lu-Culligan,
  • Alexandra Tabachnikova,
  • Eddy Pérez-Then,
  • Maria Tokuyama,
  • Hannah J. Lee,
  • Carolina Lucas,
  • Valter Silva Monteiro,
  • Marija Miric,
  • Vivian Brache,
  • Leila Cochon,
  • M. Catherine Muenker,
  • Subhasis Mohanty,
  • Jiefang Huang,
  • Insoo Kang,
  • Charles Dela Cruz,
  • Shelli Farhadian,
  • Melissa Campbell,
  • Inci Yildirim,
  • Albert C. Shaw,
  • Shuangge Ma,
  • Sten H. Vermund,
  • Albert I. Ko,
  • Saad B. Omer,
  • Akiko Iwasaki

Journal volume & issue
Vol. 20, no. 5

Abstract

Read online

The impact of Coronavirus Disease 2019 (COVID-19) mRNA vaccination on pregnancy and fertility has become a major topic of public interest. We investigated 2 of the most widely propagated claims to determine (1) whether COVID-19 mRNA vaccination of mice during early pregnancy is associated with an increased incidence of birth defects or growth abnormalities; and (2) whether COVID-19 mRNA-vaccinated human volunteers exhibit elevated levels of antibodies to the human placental protein syncytin-1. Using a mouse model, we found that intramuscular COVID-19 mRNA vaccination during early pregnancy at gestational age E7.5 did not lead to differences in fetal size by crown-rump length or weight at term, nor did we observe any gross birth defects. In contrast, injection of the TLR3 agonist and double-stranded RNA mimic polyinosinic-polycytidylic acid, or poly(I:C), impacted growth in utero leading to reduced fetal size. No overt maternal illness following either vaccination or poly(I:C) exposure was observed. We also found that term fetuses from these murine pregnancies vaccinated prior to the formation of the definitive placenta exhibit high circulating levels of anti-spike and anti-receptor-binding domain (anti-RBD) antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) consistent with maternal antibody status, indicating transplacental transfer in the later stages of pregnancy after early immunization. Finally, we did not detect increased levels of circulating anti-syncytin-1 antibodies in a cohort of COVID-19 vaccinated adults compared to unvaccinated adults by ELISA. Our findings contradict popular claims associating COVID-19 mRNA vaccination with infertility and adverse neonatal outcomes. The impact of COVID-19 mRNA vaccination on pregnancy and fertility has become a major topic of public interest. This study shows that after inoculation of pregnant mice with COVID mRNA vaccines, no birth defects or growth restrictions were found, and no induction of anti-syncytin-1 antibodies was detected in a longitudinal human cohort compared to unvaccinated volunteers.